PTHS

Pelthos Therapeutics
PTHS

Upgrade to unlock
Buy
Hold
Sell

3 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
Avg. target
$54
136% upside
High target

3 analyst ratings

positive
0  neutral
0%
negative
Analyst & Firm Rating Price Target Upside
Downside 		Date
Piper Sandler
Piper Sandler
David Amsellem
100% 1-yr PTHS win rate
27 Feb ‘26 5 days ago
Roth Capital
Roth Capital
Jonathan Aschoff
50% 1-yr PTHS win rate
26 Feb ‘26 6 days ago
Oppenheimer
Oppenheimer
Jeff Jones
33% 1-yr PTHS win rate
26 Jan ‘26 1 month ago